JP2005506039A - アフィニティ選択に基づいた疎水性タンパク質のスクリーニング - Google Patents

アフィニティ選択に基づいた疎水性タンパク質のスクリーニング Download PDF

Info

Publication number
JP2005506039A
JP2005506039A JP2002558022A JP2002558022A JP2005506039A JP 2005506039 A JP2005506039 A JP 2005506039A JP 2002558022 A JP2002558022 A JP 2002558022A JP 2002558022 A JP2002558022 A JP 2002558022A JP 2005506039 A JP2005506039 A JP 2005506039A
Authority
JP
Japan
Prior art keywords
protein
tag
seq
hydrophobic
cooh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002558022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506039A5 (https=
Inventor
エス． フェルシュ、ジェイソン
アレン ジュニア アニス、ディビッド
カルガートギ、クリシュナ
エム． ナッシュ、ヒュー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neogenesis Pharmaceuticals Inc
Original Assignee
Neogenesis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neogenesis Pharmaceuticals Inc filed Critical Neogenesis Pharmaceuticals Inc
Publication of JP2005506039A publication Critical patent/JP2005506039A/ja
Publication of JP2005506039A5 publication Critical patent/JP2005506039A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/99—Miscellaneous (1.14.99)
    • C12Y114/99001—Prostaglandin-endoperoxide synthase (1.14.99.1), i.e. cyclooxygenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2002558022A 2000-12-29 2001-12-19 アフィニティ選択に基づいた疎水性タンパク質のスクリーニング Pending JP2005506039A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25897000P 2000-12-29 2000-12-29
PCT/US2001/050088 WO2002057792A2 (en) 2000-12-29 2001-12-19 Affinity selection-based screening of hydrophobic proteins

Publications (2)

Publication Number Publication Date
JP2005506039A true JP2005506039A (ja) 2005-03-03
JP2005506039A5 JP2005506039A5 (https=) 2005-12-22

Family

ID=22982920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002558022A Pending JP2005506039A (ja) 2000-12-29 2001-12-19 アフィニティ選択に基づいた疎水性タンパク質のスクリーニング

Country Status (5)

Country Link
US (1) US20020164617A1 (https=)
EP (1) EP1379878A2 (https=)
JP (1) JP2005506039A (https=)
CA (1) CA2433354A1 (https=)
WO (1) WO2002057792A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015527074A (ja) * 2012-09-10 2015-09-17 ザ ジョンズ ホプキンズ ユニヴァーシティー 細胞表面におけるタンパク質の発現及びシグナル伝達を増大するための組成物及び方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004099774A2 (en) * 2003-05-07 2004-11-18 Cellzome Ag Processes for the identification of medical targets by screening an active agent for binding interactions
US20080097084A1 (en) * 2003-09-25 2008-04-24 Mendez Michael J Rho Antibody And Tag To Purify Cell Surface Proteins
CA2633790C (en) 2005-12-22 2016-08-09 Henry M. Krause Methods and compositions for the detection and isolation of ligands
US8468002B2 (en) * 2007-03-22 2013-06-18 Infosys Limited Annotating descriptions of chemical compounds
WO2017209990A1 (en) * 2016-05-31 2017-12-07 Exxonmobil Upstream Research Company METHODS FOR lSOLATING NUCLEIC ACIDS FROM SAMPLES
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
CN115851686A (zh) * 2022-07-29 2023-03-28 复旦大学附属中山医院 Sirt6 h133y蛋白及其富集豆蔻酰化修饰肽段的方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
WO1994021665A1 (en) * 1993-03-24 1994-09-29 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
WO1995002611A1 (en) * 1993-07-16 1995-01-26 Schering Corporation Cell surface protein present on nk (natural killer cells) named dx1
US6017768A (en) * 1994-05-06 2000-01-25 Pharmacopeia, Inc. Combinatorial dihydrobenzopyran library
US5962337A (en) * 1995-06-29 1999-10-05 Pharmacopeia, Inc. Combinatorial 1,4-benzodiazepin-2,5-dione library
EP0914608A1 (en) * 1996-05-09 1999-05-12 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
GB9610813D0 (en) * 1996-05-23 1996-07-31 Pharmacia Spa Combinatorial solid phase synthesis of a library of benzufuran derivatives
GB9610811D0 (en) * 1996-05-23 1996-07-31 Pharmacia Spa Combinatorial solid phase synthesis of a library of indole derivatives
US6025371A (en) * 1996-10-28 2000-02-15 Versicor, Inc. Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
US6114309A (en) * 1997-11-21 2000-09-05 Incara Research Laboratories Combinatorial library of moenomycin analogs and methods of producing same
US6207861B1 (en) * 1998-01-05 2001-03-27 Neogenesis, Inc. Method for producing and screening mass coded combinatorial libraries for drug discovery and target validation
DE69935905D1 (de) * 1998-01-15 2007-06-06 Whitehead Biomedical Inst Fettsäure transportproteine
JP2002517466A (ja) * 1998-06-08 2002-06-18 アドバンスド メディスン インコーポレーテッド 新規カリウムチャンネル薬剤およびそれらの用途
US6147344A (en) * 1998-10-15 2000-11-14 Neogenesis, Inc Method for identifying compounds in a chemical mixture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015527074A (ja) * 2012-09-10 2015-09-17 ザ ジョンズ ホプキンズ ユニヴァーシティー 細胞表面におけるタンパク質の発現及びシグナル伝達を増大するための組成物及び方法

Also Published As

Publication number Publication date
WO2002057792A2 (en) 2002-07-25
WO2002057792A3 (en) 2003-11-06
CA2433354A1 (en) 2002-07-25
US20020164617A1 (en) 2002-11-07
EP1379878A2 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
US20220283171A1 (en) Methods and systems for producing nanolipoprotein particles
Klammt et al. Evaluation of detergents for the soluble expression of α‐helical and β‐barrel‐type integral membrane proteins by a preparative scale individual cell‐free expression system
Chait et al. Revealing higher order protein structure using mass spectrometry
Li et al. Preparation of lipid nanodiscs with lipid mixtures
Murray et al. Detergent optimized membrane protein reconstitution in liposomes for solid state NMR
JP2012500963A (ja) 原形質膜小胞、その製作方法及びその使用方法
Kaushansky et al. A quantitative study of the recruitment potential of all intracellulartyrosine residues on EGFR, FGFR1 and IGF1R
Shi et al. Purification and characterization of a recombinant G-protein-coupled receptor, Saccharomyces cerevisiae Ste2p, transiently expressed in HEK293 EBNA1 cells
Friesen et al. Quaternary Structure of the Lactose Transport Protein ofStreptococcus thermophilus in the Detergent-solubilized and Membrane-reconstituted State
Vostrikov et al. Accommodation of a central arginine in a transmembrane peptide by changing the placement of anchor residues
Kirsch et al. Membrane protein binding interactions studied in live cells via diethylpyrocarbonate covalent labeling mass spectrometry
JP2005506039A (ja) アフィニティ選択に基づいた疎水性タンパク質のスクリーニング
US7176035B2 (en) Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
CN108779181A (zh) 生产红细胞蛋白质的方法
JP5021143B2 (ja) 医療および他の用途に用いる化合物の発見および創製のための方法
Naider et al. Peptide fragments as models to study the structure of a G‐protein coupled receptor: The α‐factor receptor of Saccharomyces cerevisiae
AU2002246810A1 (en) Affinity selection-based screening of hydrophobic proteins
AU2001250029B2 (en) Method of monitoring HIV assembly and maturation
Campuzano A Research Journey: Over a Decade of Denaturing and Native-MS Analyses of Hydrophobic and Membrane Proteins in Amgen Therapeutic Discovery
US20080070800A1 (en) Elucidation of Gene Function
US20220270707A1 (en) Saposin lipoprotein particles and libraries from crude membranes
Heim Expression, purification, refolding and structure analysis of stabilized G protein-coupled receptors expressed in E. coli inclusion bodies
WO2025121411A1 (ja) 改変近接依存性修飾酵素
JP2006512080A (ja) バインディングザイムアレイ及びハイスループットプロテオミクス方法
EP1410020A2 (en) Test system and method suitable for selecting test materials and formulations

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071023

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080325